FinancialGovernment SolutionsLegalReuters News AgencyRisk Management SolutionsTax & AccountingBlog: Answers OnInnovation @ Thomson Reuters
Directory of sites
Login
Contact
Support
Detained In Myanmar
Energy & Environment
Brexit
North Korea
Charged: The Future of Autos
Future of Money
Breakingviews
Market News
February 15, 2018 / 9:35 PM / 3 months ago

BRIEF-Dova Pharmaceuticals Reports Qtrly Loss Per Share $‍0.36​

Reuters Staff

1 Min Read

Feb 15 (Reuters) - Dova Pharmaceuticals Inc:

* DOVA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 OPERATING AND FINANCIAL RESULTS

* DOVA PHARMACEUTICALS INC QTRLY LOSS PER SHARE $‍0.36​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

© 2018 Reuters. All Rights Reserved.